Luminexa LLC – Trademark Portfolio

Entity Type: 16

Luminexa LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include L and LUMINEXA. The owner is based in Austin, TX.

8911 North Capital of Texas Highway, Suite 4200 #1194

Austin, TX 78759

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LUMINEXA
LUMINEXA
Registered 2025
L
L
Registered 2025

Trademark Classifications

Luminexa LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Luminexa LLC have?

Luminexa LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Luminexa LLC file in?

Luminexa LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Luminexa LLC's most well-known trademarks?

Luminexa LLC's registered trademark portfolio includes well-known marks such as L and LUMINEXA. These are among 2 currently registered trademarks in the portfolio.

What is Luminexa LLC's trademark registration success rate?

Luminexa LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.